These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8170550)

  • 1. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination.
    Rodriguez M; Karnes WE; Bartleson JD; Pineda AA
    Neurology; 1993 Jun; 43(6):1100-4. PubMed ID: 8170550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unsuccessful trial of immunomodulatory therapy in delayed posthypoxic demyelination.
    Khot S; Walker M; Lacy JM; Oakes P; Longstreth WT
    Neurocrit Care; 2007; 7(3):253-6. PubMed ID: 17565450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of therapeutic plasmapheresis in demyelinating neurologic disorders.
    Tindall RS; Rollins JA
    South Med J; 1986 Aug; 79(8):991-7. PubMed ID: 3016910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study].
    Meca-Lallana JE; Rodríguez-Hilario H; Martínez-Vidal S; Saura-Luján I; Carretón-Ballester A; Escribano-Soriano JB; Martín-Fernández J; Genovés-Aleixandre A; Mateo-Bosch E; Fernández-Barreiro A
    Rev Neurol; 2003 Nov 16-30; 37(10):917-26. PubMed ID: 14634919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent simultaneous central nervous system demyelination with possible peripheral demyelination / nodopathy in a seronegative patient.
    Inan B; Bekircan-Kurt CE; Yildiz FG; Gocmen R; Temucin CM; Tuncer A; Tan E; Erdem-Ozdamar S
    Ideggyogy Sz; 2024 Sep; 77(9-10):357-360. PubMed ID: 39352255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Steroid therapy and plasmapheresis in chronic inflammatory demyelinating polyradiculoneuropathy: a long-term follow-up study].
    Hanaoka N; Hanyu N; Yanagisawa N
    Rinsho Shinkeigaku; 1998 Mar; 38(3):208-12. PubMed ID: 9711115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmapheresis in the treatment of acute relapsing inflammatory demyelinating polyradiculoneuropathy associated with human immunodeficiency virus infection: a case report.
    Wuest D; Goldfinger D
    J Clin Apher; 1988; 4(4):149-51. PubMed ID: 3220816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fulminant Demyelinating Diseases of the Central Nervous System.
    Bevan CJ; Cree BA
    Semin Neurol; 2015 Dec; 35(6):656-66. PubMed ID: 26595866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood multiple sclerosis treated with plasmapheresis.
    Takahashi I; Sawaishi Y; Takeda O; Enoki M; Takada G
    Pediatr Neurol; 1997 Jul; 17(1):83-7. PubMed ID: 9308985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased proliferation of blood mononuclear cells after plasmapheresis treatment of patients with demyelinating disease.
    Dau PC
    J Neuroimmunol; 1990 Nov; 30(1):15-21. PubMed ID: 2229403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Double filtration plasmapheresis (DFPP) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Kumazawa K; Yuasa N; Mitsuma T; Nagamatsu M; Sobue G
    Rinsho Shinkeigaku; 1998 Aug; 38(8):719-23. PubMed ID: 9916516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination--possible markers for an antibody-mediated process.
    Brück W; Neubert K; Berger T; Weber JR
    Mult Scler; 2001 Jun; 7(3):173-7. PubMed ID: 11475441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis in neurologic disorders.
    Dau PC
    Muscle Nerve; 1980; 3(6):529. PubMed ID: 6161306
    [No Abstract]   [Full Text] [Related]  

  • 14. Peripheral nerve demyelination in multiple sclerosis.
    Misawa S; Kuwabara S; Mori M; Hayakawa S; Sawai S; Hattori T
    Clin Neurophysiol; 2008 Aug; 119(8):1829-1833. PubMed ID: 18495530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic apheresis in pediatric patients with acute CNS inflammatory demyelinating disease.
    Koziolek M; Mühlhausen J; Friede T; Ellenberger D; Sigler M; Huppke B; Gärtner J; Müller GA; Huppke P
    Blood Purif; 2013; 36(2):92-7. PubMed ID: 24021839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.
    Llufriu S; Castillo J; Blanco Y; Ramió-Torrentà L; Río J; Vallès M; Lozano M; Castellà MD; Calabia J; Horga A; Graus F; Montalban X; Saiz A
    Neurology; 2009 Sep; 73(12):949-53. PubMed ID: 19770470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double filtration plasmapheresis in the treatment of inflammatory polyneuropathy.
    Chiu HC; Chen WH; Yeh JH
    Ther Apher; 1997 May; 1(2):183-6. PubMed ID: 10225768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of chronic demyelinating polyneuropathy with benign IgM anti-myelin-associated glycoprotein paraproteinenia--transient improvement with weekly plasmapheresis].
    Muramoto T; Yamashita Y; Ohnishi A; Saito T; Kajiyama K; Shirokuchi A
    Rinsho Shinkeigaku; 1991 Jan; 31(1):38-43. PubMed ID: 1710553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favourable response to plasma exchange in tumefactive CNS demyelination with delayed B-cell response.
    Seifert CL; Wegner C; Sprenger T; Weber MS; Brück W; Hemmer B; Sellner J
    Mult Scler; 2012 Jul; 18(7):1045-9. PubMed ID: 22086900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of MS relapses in the era of disease-modifying therapy.
    Stoppe M; Busch M; Krizek L; Then Bergh F
    BMC Neurol; 2017 Aug; 17(1):151. PubMed ID: 28784102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.